First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration

<b>Background</b>: To evaluate the outcomes of intravitreal faricimab (IVF) for refractory neovascular age-related macular degeneration (nAMD) and investigate the impact of baseline optical coherence tomography, biomarkers for total IVF injections are needed. <b>Methods</b>: A retrospective analysis...

Cijeli opis

Bibliografski detalji

Glavni autori:	Wissam Aljundi, Loay Daas, Shady Suffo, Berthold Seitz, Alaa Din Abdin
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-03-01
Serija:	Pharmaceutics
Teme:	faricimab anti-VEGF Ang-2 age-related macular degeneration subretinal fluid
Online pristup:	https://www.mdpi.com/1999-4923/16/4/470
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!